Form 4: BioNexus Gene Lab Director Receives Stock Grant
Insider Transaction (Form 4)
Jook Yuen Low, a Director of BioNexus Gene Lab Corp, received 16,129 shares of common stock on August 13, 2026.
Summary
- Grant/award: acquired 16,129 Common Stock on August 13, 2026; holds 17,390 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jook Yuen Low — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Grant/award | Common Stock | 16,129 | — | — | 17,390 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Grant/award (16,129 shares) |
Keywords
insider transaction, Form 4, BGLC, BioNexus Gene Lab Corp, neutral, Jook Yuen Low
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.